retatrutide triple agonist obesity trial ๐จ Today, retatrutide, the GIP/GLP-1/glucagon agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent and type 2 diabetes. ๐ Mean body weight change at 80 weeks: โฌ๏ธ Lilly orforglipron oral GLP-1 phase
Pay in 4 interest-free payments of $6.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Jul 31 - Aug 5

























